South Korea Antithrombotic Drugs Market (2025-2031) | Competitive Landscape, Industry, Forecast, Share, Outlook, Size & Revenue, Growth, Companies, Segmentation, Trends, Value, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 South Korea Country Macro Economic Indicators

3.2 South Korea Antithrombotic Drugs Market Revenues & Volume, 2021 & 2031F

3.3 South Korea Antithrombotic Drugs Market - Industry Life Cycle

3.4 South Korea Antithrombotic Drugs Market - Porter's Five Forces

3.5 South Korea Antithrombotic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 South Korea Antithrombotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.7 South Korea Antithrombotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.8 South Korea Antithrombotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 South Korea Antithrombotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.10 South Korea Antithrombotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cardiovascular diseases in South Korea

4.2.2 Growing awareness about the importance of antithrombotic drugs for preventing blood clots

4.2.3 Advancements in healthcare infrastructure and technology in South Korea

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of antithrombotic drugs

4.3.2 High cost associated with antithrombotic drug development and treatment

4.3.3 Potential side effects and risks associated with prolonged use of antithrombotic drugs

6.1 South Korea Antithrombotic Drugs Market, By Type

6.1.1 Overview and Analysis

6.1.2 South Korea Antithrombotic Drugs Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 South Korea Antithrombotic Drugs Market Revenues & Volume, By Apixaban, 2021- 2031F

6.1.4 South Korea Antithrombotic Drugs Market Revenues & Volume, By Debigatran, 2021- 2031F

6.1.5 South Korea Antithrombotic Drugs Market Revenues & Volume, By Edoxaban, 2021- 2031F

6.1.6 South Korea Antithrombotic Drugs Market Revenues & Volume, By Fondaparinux, 2021- 2031F

6.1.7 South Korea Antithrombotic Drugs Market Revenues & Volume, By Heparin, 2021- 2031F

6.1.8 South Korea Antithrombotic Drugs Market Revenues & Volume, By Rivaroxaban, 2021- 2031F

6.2 South Korea Antithrombotic Drugs Market, By Drug Class

6.2.1 Overview and Analysis

6.2.2 South Korea Antithrombotic Drugs Market Revenues & Volume, By Thrombolytic Drugs, 2021- 2031F

6.2.3 South Korea Antithrombotic Drugs Market Revenues & Volume, By Anti-Platelet Drugs, 2021- 2031F

6.2.4 South Korea Antithrombotic Drugs Market Revenues & Volume, By Anticoagulants, 2021- 2031F

6.2.5 South Korea Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.3 South Korea Antithrombotic Drugs Market, By Indication

6.3.1 Overview and Analysis

6.3.2 South Korea Antithrombotic Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F

6.3.3 South Korea Antithrombotic Drugs Market Revenues & Volume, By Stroke, 2021- 2031F

6.3.4 South Korea Antithrombotic Drugs Market Revenues & Volume, By Deep vein thrombosis (DVT), 2021- 2031F

6.3.5 South Korea Antithrombotic Drugs Market Revenues & Volume, By Pulmonary Embolism (PE), 2021- 2031F

6.3.6 South Korea Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.4 South Korea Antithrombotic Drugs Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 South Korea Antithrombotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F

6.4.3 South Korea Antithrombotic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F

6.4.4 South Korea Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.5 South Korea Antithrombotic Drugs Market, By End-Users

6.5.1 Overview and Analysis

6.5.2 South Korea Antithrombotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 South Korea Antithrombotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.5.4 South Korea Antithrombotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F

6.5.5 South Korea Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.6 South Korea Antithrombotic Drugs Market, By Distribution Channel

6.6.1 Overview and Analysis

6.6.2 South Korea Antithrombotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.6.3 South Korea Antithrombotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.6.4 South Korea Antithrombotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.6.5 South Korea Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F

7.1 South Korea Antithrombotic Drugs Market Export to Major Countries

7.2 South Korea Antithrombotic Drugs Market Imports from Major Countries

8.1 Patient adherence rate to antithrombotic drug therapy

8.2 Number of new antithrombotic drug formulations approved for use in South Korea

8.3 Rate of hospitalizations due to thrombotic events despite antithrombotic drug therapy

9.1 South Korea Antithrombotic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 South Korea Antithrombotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.3 South Korea Antithrombotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F

9.4 South Korea Antithrombotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 South Korea Antithrombotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.6 South Korea Antithrombotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 South Korea Antithrombotic Drugs Market Revenue Share, By Companies, 2024

10.2 South Korea Antithrombotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters